RIVARA, Mirko
 Distribuzione geografica
Continente #
EU - Europa 1.304
NA - Nord America 1.282
AS - Asia 618
AF - Africa 25
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.235
Nazione #
US - Stati Uniti d'America 1.256
CN - Cina 404
FI - Finlandia 260
SE - Svezia 239
IT - Italia 237
IE - Irlanda 230
SG - Singapore 176
UA - Ucraina 136
DE - Germania 105
GB - Regno Unito 40
TR - Turchia 32
CA - Canada 26
CI - Costa d'Avorio 25
CZ - Repubblica Ceca 15
BE - Belgio 14
FR - Francia 7
IN - India 6
NL - Olanda 6
PT - Portogallo 6
CL - Cile 3
LT - Lituania 3
RU - Federazione Russa 2
AL - Albania 1
AU - Australia 1
BR - Brasile 1
EU - Europa 1
LI - Liechtenstein 1
RO - Romania 1
RS - Serbia 1
Totale 3.235
Città #
Dublin 230
Chandler 226
Jacksonville 154
Singapore 133
Beijing 99
Ann Arbor 97
Ashburn 86
Boardman 69
Dearborn 67
Parma 65
Nanjing 62
Shanghai 47
Princeton 45
Milan 37
New York 32
Wilmington 32
Izmir 31
San Mateo 29
Chicago 27
Abidjan 25
Helsinki 22
Toronto 20
Nanchang 17
Shenyang 17
Kunming 16
Guangzhou 15
Hefei 15
Jinan 15
Bremen 14
Brussels 14
Des Moines 14
Hebei 14
Los Angeles 14
Seattle 14
Jiaxing 11
Munich 11
Santa Clara 11
Brno 10
Woodbridge 10
London 8
Changsha 7
Frankfurt am Main 7
Piacenza 6
Reggio Emilia 6
Tianjin 6
Auburn Hills 5
Dallas 5
Falls Church 5
Modena 5
Norwalk 5
Abbiategrasso 4
Bologna 4
Brescia 4
Chengdu 4
Düsseldorf 4
Roncadelle 4
Buccinasco 3
Castelo Branco 3
Fremont 3
Grafing 3
Gualtieri 3
Haikou 3
Hangzhou 3
Ningbo 3
Novi di Modena 3
Ottawa 3
Pavia 3
Reggio Nell'emilia 3
St Andrews 3
Taiyuan 3
Taizhou 3
Trezzano Sul Naviglio 3
Vobarno 3
Wuhan 3
Zhengzhou 3
Baotou 2
Castelcovati 2
Cereda 2
Cesena 2
Chongqing 2
Florence 2
Fuzhou 2
Grezzago 2
Hertford 2
Lanzhou 2
Miami 2
Montepulciano 2
Naples 2
Oakville 2
Palermo 2
Terni 2
Torino 2
Xian 2
Alzate Brianza 1
Arzignano 1
Augusta 1
Brooklyn 1
Cambridge 1
Espoo 1
Fairfield 1
Totale 2.056
Nome #
QSAR study of 2-aminobenzimidazole derivatives as H3 antagonists 98
The Role of HB-Donor Groups in the Heterocyclic Polar Fragment of H3-Antagonists. I. Synthesis and Biological Assays 98
Cognition enhancing effect in rats of a selected histamine H3 receptor antagonist with good brain penetration 94
5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line 90
3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line 88
Validation of a histamine H3 receptor model through structure–activity relationships for classical H3 antagonists 87
COMPOSITIONS AND METHODS FOR BLOCKING SODIUM CHANNELS 85
A Short and Efficient Synthesis of the Selective H4 Receptor Agonist 4-Methylhistamine 84
Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design 82
Novel Sodium Channel Antagonists in the Treatment of Neuropathic Pain 81
COMPOSITIONS AND METHODS FOR BLOCKING SODIUM CHANNELS 81
Dibasic non-imidazole histamine H3 receptor antagonists with a rigid byphenyl scaffold. 80
Antioxidant and cytoprotective activity of indole derivatives related to melatonin 80
Drug repurposing approaches to fight Dengue virus infection and related diseases 79
Development of a GPCR model for SAR interpretation of classical and new H3 antagonists 79
Chiral NMR discrimination of the diastereoisomeric salts of the H(3)-antagonist 2-[3-(1H-imidazol-4-ylmethyl)piperidin-1-yl]-1H-benzimidazole. 78
In vitro and in vivo pharmacological analysis of imidazole-free histamine H3 receptor antagonists: promising results for a brain-penetrating H3 blocker with weak anticholinesterase activity. 77
Gene-Delivery Ability of New Hydrogenated and Partially Fluorinated Gemini bispyridinium Surfactants with Six Methylene Spacers 77
Synthesis, biological activity, QSAR and QSPR study of 2/aminobenzimidazole derivatives as potent H3-antagonists 76
Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity. 75
Advances in Design and Development of Sodium Channel Blockers. 74
2,4(5)-Diarylimidazoles: Synthesis and Biological Evaluation of a New Class of Sodium Channel Blockers against hNav1.2 73
Development and validation of a LC-MS method with electrospray ionization for the determination of the imidazole H(3) antagonist ROS203 in rat plasma. 72
Imidazole H3-antagonists: Relationship between Structure and Ex-vivo binding to Rat Brain H3-Receptors 71
NMR Analysis of a Series of Imidazobenzoxazines 67
Synthesis and biological evaluation of new non-imidazole H(3)-receptor antagonists of the 2-aminobenzimidazole series 66
Anticonvulsant Activity of 2,4(5)-Diarylimidazoles in Mice and Rat Models 65
Synthesis, antioxidant activity and structure-activity relationships for a new series of 2-(N-acylaminoethyl)indoles with melatonin-like cytoprotective activity 65
Inhibition of NaV1.6 sodium channel currents by a novel series of 1,4-disubstituted-triazole derivatives obtained via copper-catalyzed click chemistry 65
COMPOSITIONS AND METHODS FOR BLOCKING SODIUM CHANNELS 65
2,4(5)-Diarylimidazoles as Inhibitors of hNaV1.2 Sodium Channels: Pharmacological Evaluationand Structure-Property Relationships 63
Chemico-Physical Properties of Some 1,1′-Bis-alkyl-2,2′-hexane-1,6-diyl-bispyridinium Chlorides Hydrogenated and Partially Fluorinated for Gene Delivery 62
Biological evaluation of imidazobenzoxazines, imidazobenzoxazin-5-ones and imidazobenzoxazin-5-thiones as sodium channel blockers 62
Sodium Channel Blocking Activity and In-vivo Testing of New Phenyl-imidazole Derivatives. 62
Anticonvulsant Activity of 2,4(1H)-Diarylimidazoles in Mice and Rats Acute Seizure Models 60
Sodium channel blockers: a patent review (2010 - 2014) 57
A Practical Synthesis of 2,4(5)-Diarylimidazoles from Simple Building Blocks 56
Synthesis and stability in biological media of 1H-imidazole-1-carboxylates of ROS203, an antagonist of the histamine H3 receptor. 54
Sodium Channel Blockers as Therapeutic Target for Treating Epilepsy: Recent Updates 52
Recent Advances in the Medicinal Chemistry of Sodium Channel Blockers and their Therapeutic Potential 51
In vivo Screening of Diarylimidazoles as Anticonvulsant Agents 49
Sodium channel blockers for neuropathic pain. 48
Microwave Assisted Efficient Synthesis of Imidazole-based Privileged Structure 44
MV1035 Overcomes Temozolomide Resistance in Patient-Derived Glioblastoma Stem Cell Lines 43
NaV1.1 and NaV1.6 selective compounds reduce the behavior phenotype and epileptiform activity in a novel zebrafish model for Dravet syndrome 42
Potential in-vitro antiviral activity of MV1035 on SARS-CoV-2 wild type viruses 37
NEW ALKBH2 AND ALKBH5 INHIBITORS FOR TREATING GLIOBLASTOMA 37
Subtype-selective small molecule inhibitors reveal a fundamental role for Nav1.7 in nociceptor electrogenesis, axonal conduction and presynaptic release 32
New ALKBH2 and ALKBH5 inhibitors for treating glioblastoma 20
IMIDAZOBENZOXAZIN-5-THIONE (MV1035) TO OVERCOME THE BLOOD-BRAIN BARRIER AND TARGET CNS DISEASES 16
Totale 3.299
Categoria #
all - tutte 13.728
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.728


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020385 0 0 0 0 46 52 92 16 55 70 11 43
2020/2021304 11 39 24 16 31 9 47 10 55 16 42 4
2021/2022229 3 2 5 18 14 7 29 26 21 17 17 70
2022/2023929 106 108 68 57 71 118 17 44 275 12 36 17
2023/2024411 22 32 11 14 43 84 38 29 19 21 35 63
2024/2025373 64 78 99 90 42 0 0 0 0 0 0 0
Totale 3.299